Fulvestrant for the treatment of advanced breast cancer
Introduction: The current issues with endocrine therapy for treatment of advanced breast cancer include balance of efficacy of therapy versus tolerability as well as hormone resistance. The efficacy of fulvestrant, a selective oestrogen receptor degrader (SERD), has been demonstrated in hormone rece...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis
2018
|
| Online Access: | http://eprints.nottingham.ac.uk/52665/ http://eprints.nottingham.ac.uk/52665/ http://eprints.nottingham.ac.uk/52665/ http://eprints.nottingham.ac.uk/52665/1/Fulvestrant-%20final%20edit.pdf |